Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
11 hedge funds and large institutions have $22.6M invested in Liminal BioSciences Inc. Common Shares in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
8% less funds holding
Funds holding: 12 → 11 (-1)
20% less capital invested
Capital invested by funds: $28.1M → $22.6M (-$5.58M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$164K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.33K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.61K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.89K |
| 5 |
JP Morgan Chase
New York
|
+$2.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$14.4K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.44K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$180 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
1
Consonance Capital Management
New York
| $22M | – | – | – |
|
|
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $251K | -$14.4K | -160 | -4% |
|
|
3
Morgan Stanley
New York
| $233K | +$164K | +1,818 | +108% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $60K | +$4.33K | +48 | +6% |
|
|
5
JP Morgan Chase
New York
| $16K | +$2.71K | +30 | +14% |
|
|
6
UBS Group
Zurich,
Switzerland
| $10K | +$2.89K | +32 | +27% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $6K | +$3.61K | +40 | +67% |
|
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | -$1.44K | -16 | -36% |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $1.56K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$1K | -11 | Closed |
|
|
11
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$180 | -2 | -40% |
|
LMNL Hedge Fund Activity: Q1 2020 in Review
11 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q1 2020, worth a combined $22.6M — down 20% from $28.1M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LMNL and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was Morgan Stanley, adding an estimated $164K. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $14.4K.
- 11 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q1 2020, down from 12 in Q4 2019.
- Funds reported $22.6M of Liminal BioSciences Inc. Common Shares stock for Q1 2020, down 20% quarter-over-quarter.
- 0 funds opened new Liminal BioSciences Inc. Common Shares positions in Q1 2020 and 1 closed out, a net change of -1 holder.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q1 2020 was Morgan Stanley, an estimated $164K added.
- The largest Liminal BioSciences Inc. Common Shares seller in Q1 2020 was Federation des caisses Desjardins du Quebec, an estimated $14.4K sold.
Based on aggregated 13F filings for Q1 2020.